期刊
NATURE IMMUNOLOGY
卷 2, 期 11, 页码 1061-1066出版社
NATURE AMERICA INC
DOI: 10.1038/ni720
关键词
-
类别
资金
- NIAID NIH HHS [AI25532] Funding Source: Medline
- NIDDK NIH HHS [DK52510, DK47677, DK43351] Funding Source: Medline
The cytokine macrophage-migration inhibitory factor (MIF) is secreted by a number of cell types upon induction by lipopolysaccharide (LPS). Because colitis is dependent on interplay between the mucosal immune system and intestinal bacteria, we investigated the role of MIF in experimental colitis. MIF-deficient mice failed to develop disease, but reconstitution of MIF-deficient mice with wild-type innate immune cells restored colitis. In addition, established colitis could be treated with anti-MIF immunoglobulins. Thus, murine colitis is dependent on continuous MIF production by the innate immune system. Because we found increased plasma MIF concentrations in patients with Crohn's disease, these data suggested that MIF is a new target for intervention in Crohn's disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据